Amgen – Amgen Inc. stock underperforms Thursday when compared to competitors
Shares of Amgen Inc.
shed 0.84% to $234.71 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index
rising 0.68% to 4,211.47 and the Dow Jones Industrial Average
rising 0.71% to 34,060.36. This was the stock’s fourth consecutive day of losses. Amgen Inc. closed $41.98 short of its 52-week high ($276.69), which the company reached on January 28th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson
rose 1.37% to $164.20, Roche Holding AG Part. Cert.
fell 1.50% to $328.00, and Pfizer Inc.
fell 0.54% to $38.60. Trading volume (4.0 M) eclipsed its 50-day average volume of 2.7 M.